US 8,912,229 B2Granted

Taxane and abeo-taxane analogs

AssigneeArbor Therapeutics, LLC

InventorsJames D. McChesney, John T. Henry, Sylesh Venkataraman, Mahesh Kumar Gundluru

Life of this patent

Estimating the term…

Abstract

The present application discloses new taxane analogs, intermediates and methods for producing them. The present application is also directed to pharmaceutical formulations comprising abeo-taxanes and methods of treating cancer with the abeo-taxanes.

Claims5

Dependent claims

A compound of the formula:

and
pharmaceutically acceptable salts thereof.

Dependencies are inferred from the claim text.

Facts

Application: 14/110,423Filed 6 Apr 2012 · us provisional application
Priority: 7 Apr 2011
Published: US 2014/0093503 A13 Apr 2014
Granted: 16 Dec 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification17 codes

C07D 493/06
In which the condensed system contains two hetero rings: peri-condensed systems
A61K 31/357
Having oxygen as the only ring hetero atom, e.g. fungichromin: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…

Family

Application61/472,968Us provisional application · filed 7 Apr 2011
US 2014/0093503 A1Pre-grant publication · published 3 Apr 2014
US 8,912,229 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results